Neurology Articles

Neurology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Williams AM et al. – The most effective preventive measure is to keep the dose of the dopaminergic medication as low as possible, ensuring that it does not exceed the dose recommended by regulatory authorities. RLS augmentation needs to be treated only if it is clinically relevant—that is, if it has a significant impact on the patient’s daily activities. Mild cases should be followed closely, however. In severe cases, a change of treatment can be effective, although before taking this step, it should be verified that all factors that may affect augmentation have been excluded.


Today in Sleep...keeping you current

Daytime napping and mortality, with a special reference to cardiovascular disease: the JACC study
International Journal of Epidemiology, 11/11/09

Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis
Diabetes Care, 11/20/09

Armodafinil for Treatment of Excessive Sleepiness Associated With Shift Work Disorder: A Randomized Controlled Study
Mayo Clinic Proceedings, 11/03/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address